(215 ILCS 5/132.5)
(from Ch. 73, par. 744.5)
(a) General description. All examination reports shall be comprised of
only facts appearing upon the books, records, or other documents of the
company, its agents, or other persons examined or as ascertained from the
testimony of its officers, agents, or other persons examined concerning its
affairs and the conclusions and recommendations as the examiners find
reasonably warranted from those facts.
(b) Filing of examination report. No later than 60 days following
completion of the examination, the examiner in charge shall file with the
Department a verified written report of examination under oath. Upon
receipt of the verified report, the Department shall transmit the report to
the company examined, together with a notice that affords the company examined
a reasonable opportunity of not more than 30 days to make a written
submission or rebuttal with respect to any matters contained in the examination report.
(c) Adoption of the report on examination. Within 30 days of the end of the
period allowed for the receipt of written submissions or rebuttals, the
Director shall fully consider and review the report, together with any
written submissions or rebuttals and any relevant portions of the examiners
work papers and enter an order:
(1) Adopting the examination report as filed or with
(d) Order and procedures. All orders entered under paragraph (1) of
subsection (c) shall be accompanied by findings and conclusions resulting
from the Director's consideration and review of the examination report,
relevant examiner work papers, and any written submissions or rebuttals.
The order shall be considered a final administrative decision and may be
appealed in accordance with the Administrative Review Law. The order shall
be served upon the company by certified mail, together with a copy of the
adopted examination report. Within 30 days of the issuance of the adopted
report, the company shall file affidavits executed by each of its directors
stating under oath that they have received a copy of the adopted report and
Any hearing conducted under paragraph (3) of subsection (c) by the
Director or an authorized representative shall be conducted as a
nonadversarial confidential investigatory proceeding as necessary for the
resolution of any inconsistencies, discrepancies, or disputed issues
apparent upon the face of the filed examination report or raised by or as a
result of the Director's review of relevant work papers or by the written
submission or rebuttal of the company.
Within 20 days of the conclusion of any hearing, the Director shall enter
an order under paragraph (1) of subsection (c).
The Director shall not appoint an examiner as an authorized
representative to conduct the hearing. The hearing shall proceed
expeditiously with discovery by the company limited to the examiner's work
papers that tend to substantiate any assertions set forth in any written
submission or rebuttal. The Director or his representative may issue
subpoenas for the attendance of any witnesses or the production of any
documents deemed relevant to the investigation, whether under the control
of the Department, the company, or other persons. The documents produced
shall be included in the record, and testimony taken by the Director or his
representative shall be under oath and preserved for the record. Nothing
contained in this Section shall require the Department to disclose any
information or records that would indicate or show the existence or content
of any investigation or activity of a criminal justice agency.
The hearing shall proceed with the Director or his representative
posing questions to the persons subpoenaed. Thereafter the company and the
Department may present testimony relevant to the investigation.
Cross-examination shall be conducted only by the Director or his representative.
The company and the Department shall be permitted to make closing
statements and may be represented by counsel of their choice.
(e) Publication and use. Upon the adoption of the examination report
under paragraph (1) of subsection (c), the Director shall continue to hold
the content of the examination report as private and confidential
information for a period of 35 days, except to the extent provided in
subsection (b). Thereafter, the Director may open the report for public
inspection so long as no court of competent jurisdiction has stayed its publication.
Nothing contained in this Code shall prevent or be construed as
prohibiting the Director from disclosing the content of an examination
report, preliminary examination report or results, or any matter relating
thereto, to the insurance department of any other state or country or to law
enforcement officials of this or any other state or agency of the federal
government at any time, so long as the agency or office receiving the
report or matters relating thereto agrees in writing to hold it
confidential and in a manner consistent with this Code.
In the event the Director determines that regulatory action is
appropriate as a result of any examination, he may initiate any
proceedings or actions as provided by law.
(f) Confidentiality of ancillary information. All working papers,
recorded information, documents, and copies
thereof produced by, obtained by, or disclosed to the Director or any other
person in the course of any examination must be given confidential
treatment, are not subject to subpoena, and may not be made public by the
Director or any other persons, except to the extent provided in subsection
(e). Access may also be granted to the National Association of Insurance Commissioners.
Those parties must agree in writing before receiving the information to
provide to it the same confidential treatment as required by this Section,
unless the prior written consent of the company to which it pertains has been obtained.
This subsection (f) applies to market conduct examinations described in Section 132 of this Code.
(g) Disclosure. Nothing contained in this Code shall prevent or be construed as prohibiting the Director from disclosing the information described in subsections (e) and (f) to the Illinois Insurance Guaranty Fund regarding any member company defined in Section 534.5 if the member company has an authorized control level event as defined in Section 35A-25. The Director may disclose the information described in this subsection so long as the Fund agrees in writing to hold that information confidential, in a manner consistent with this Code, and uses that information to prepare for the possible liquidation of the member company. Access to the information disclosed by the Director to the Fund shall be limited to the Fund's staff and its counsel. The Board of Directors of the Fund may have access to the information disclosed by the Director to the Fund once the member company is subject to a delinquency proceeding under Article XIII subject to any terms and conditions established by the Director.
(Source: P.A. 102-929, eff. 5-27-22.)